Showing 1 - 20 results of 38 for search 'Frédérique Penault‐Llorca', query time: 0.06s Refine Results
  1. 1
    From Targeting Somatic Mutations to Finding Inherited Cancer Predispositions: The Other Side of the Coin

    From Targeting Somatic Mutations to Finding Inherited Cancer Predispositions: The Other Side of the Coin by Pascal Pujol, Thibault De La Motte Rouge, Frédérique Penault-Llorca

    Published 2019-07-01
    Get full text
    Article
  2. 2
    Breaking down the Contradictory Roles of Histone Deacetylase SIRT1 in Human Breast Cancer

    Breaking down the Contradictory Roles of Histone Deacetylase SIRT1 in Human Breast Cancer by Khaldoun Rifaï, Mouhamed Idrissou, Frédérique Penault-Llorca, Yves-Jean Bignon, Dominique Bernard-Gallon

    Published 2018-10-01
    Get full text
    Article
  3. 3
    Mini-P-gp and P-gp Co-Expression in Brown Trout Erythrocytes: A Prospective Blood Biomarker of Aquatic Pollution

    Mini-P-gp and P-gp Co-Expression in Brown Trout Erythrocytes: A Prospective Blood Biomarker of Aquatic Pollution by Emeline Valton, Christian Amblard, François Desmolles, Bruno Combourieu, Frédérique Penault-Llorca, Mahchid Bamdad

    Published 2015-01-01
    Get full text
    Article
  4. 4
    PARP Inhibitors: A Major Therapeutic Option in Endocrine-Receptor Positive Breast Cancers

    PARP Inhibitors: A Major Therapeutic Option in Endocrine-Receptor Positive Breast Cancers by Laetitia Collet, Julien Péron, Frédérique Penault-Llorca, Pascal Pujol, Jonathan Lopez, Gilles Freyer, Benoît You

    Published 2022-01-01
    Get full text
    Article
  5. 5
    Why is appropriate healthcare inaccessible for many European breast cancer patients? – The EBCC 12 manifesto

    Why is appropriate healthcare inaccessible for many European breast cancer patients? – The EBCC 12 manifesto by Fatima Cardoso, Fiona MacNeill, Frederique Penault-Llorca, Alexandru Eniu, Francesco Sardanelli, Elizabeth Bergsten Nordström, Philip Poortmans

    Published 2021-02-01
    Get full text
    Article
  6. 6
    Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen.

    Cellular Expression of Cyclooxygenase, Aromatase, Adipokines, Inflammation and Cell Proliferation Markers in Breast Cancer Specimen. by Samar Basu, Kristell Combe, Fabrice Kwiatkowski, Florence Caldefie-Chézet, Frédérique Penault-Llorca, Yves-Jean Bignon, Marie-Paule Vasson

    Published 2015-01-01
    Get full text
    Article
  7. 7
    PROCURE European consensus on breast cancer multigene signatures in early breast cancer management

    PROCURE European consensus on breast cancer multigene signatures in early breast cancer management by Giuseppe Curigliano, Fatima Cardoso, Michael Gnant, Nadia Harbeck, Judy King, Anne-Vibeke Laenkholm, Frédérique Penault-Llorca, Aleix Prat

    Published 2023-02-01
    Get full text
    Article
  8. 8
    The Functions of the Demethylase JMJD3 in Cancer

    The Functions of the Demethylase JMJD3 in Cancer by Anna Sanchez, Fatma Zohra Houfaf Khoufaf, Mouhamed Idrissou, Frédérique Penault-Llorca, Yves-Jean Bignon, Laurent Guy, Dominique Bernard-Gallon

    Published 2021-01-01
    Get full text
    Article
  9. 9
    Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ

    Analysis of tumour-infiltrating lymphocytes reveals two new biologically different subgroups of breast ductal carcinoma in situ by Marie Beguinot, Marie-Melanie Dauplat, Fabrice Kwiatkowski, Guillaume Lebouedec, Lucie Tixier, Christophe Pomel, Frederique Penault-Llorca, Nina Radosevic-Robin

    Published 2018-02-01
    Get full text
    Article
  10. 10
    Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer.

    Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer. by Abderrahim El Guerrab, Anne Cayre, Fabrice Kwiatkowski, Maud Privat, Jean-Marc Rossignol, Fabrice Rossignol, Frédérique Penault-Llorca, Yves-Jean Bignon

    Published 2017-01-01
    Get full text
    Article
  11. 11
    Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer

    Physical basis of the ‘magnification rule’ for standardized Immunohistochemical scoring of HER2 in breast and gastric cancer by Andreas H. Scheel, Frédérique Penault-Llorca, Wedad Hanna, Gustavo Baretton, Peter Middel, Judith Burchhardt, Manfred Hofmann, Bharat Jasani, Josef Rüschoff

    Published 2018-03-01
    Get full text
    Article
  12. 12
    Differential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancer.

    Differential impact of EGFR-targeted therapies on hypoxia responses: implications for treatment sensitivity in triple-negative metastatic breast cancer. by Abderrahim El Guerrab, Rabah Zegrour, Carine-Christiane Nemlin, Flavie Vigier, Anne Cayre, Frederique Penault-Llorca, Fabrice Rossignol, Yves-Jean Bignon

    Published 2011-01-01
    Get full text
    Article
  13. 13
    The New Serum-Free OptiPASS<sup>®</sup> Medium in Cold and Oxygen-Free Conditions: An Innovative Conservation Method for the Preservation of MDA-MB-231 Triple Negative Breast Cancer Spheroids

    The New Serum-Free OptiPASS<sup>®</sup> Medium in Cold and Oxygen-Free Conditions: An Innovative Conservation Method for the Preservation of MDA-MB-231 Triple Negative Breast Cance... by Antoine Goisnard, Clémence Dubois, Pierre Daumar, Corinne Aubel, Marie Depresle, Jean Gauthier, Bernard Vidalinc, Frédérique Penault-Llorca, Emmanuelle Mounetou, Mahchid Bamdad

    Published 2021-04-01
    Get full text
    Article
  14. 14
    Assessment of 99mTc-NTP 15-5 uptake on cartilage, a new proteoglycan tracer: Study protocol for a phase I trial (CARSPECT)

    Assessment of 99mTc-NTP 15-5 uptake on cartilage, a new proteoglycan tracer: Study protocol for a phase I trial (CARSPECT) by Emilie Thivat, Emilie Thivat, Emilie Thivat, Marion Chanchou, Marion Chanchou, Sylvain Mathieu, Sophie Levesque, Sophie Levesque, Sophie Levesque, Tommy Billoux, Tommy Billoux, Philippe Auzeloux, Nicolas Sas, Nicolas Sas, Ioana Molnar, Ioana Molnar, Ioana Molnar, Elodie Jouberton, Elodie Jouberton, Jacques Rouanet, Jacques Rouanet, Giovanna Fois, Lydia Maigne, Marie-Josephe Galmier, Frédérique Penault-Llorca, Frédérique Penault-Llorca, Frédérique Penault-Llorca, Elisabeth Miot-Noirault, Xavier Durando, Xavier Durando, Xavier Durando, Xavier Durando, Florent Cachin, Florent Cachin, Florent Cachin

    Published 2022-10-01
    Get full text
    Article
  15. 15
    LightSpot<sup>®</sup>-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer Models

    LightSpot<sup>®</sup>-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolaye... by Antoine Goisnard, Pierre Daumar, Clémence Dubois, Corinne Aubel, Manon Roux, Marie Depresle, Jean Gauthier, Bernard Vidalinc, Frédérique Penault-Llorca, Emmanuelle Mounetou, Mahchid Bamdad

    Published 2021-08-01
    Get full text
    Article
  16. 16
    Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer

    Practical considerations for optimising homologous recombination repair mutation testing in patients with metastatic prostate cancer by David Gonzalez, Joaquin Mateo, Albrecht Stenzinger, Federico Rojo, Michelle Shiller, Alexander W Wyatt, Frédérique Penault‐Llorca, Leonard G Gomella, Ros Eeles, Anders Bjartell

    Published 2021-07-01
    Get full text
    Article
  17. 17
    A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study

    A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO p... by Gwenaelle Gravis, Patricia Marino, Daniel Olive, Frederique Penault-LLorca, Jean-Pierre Delord, Clotilde Simon, Assia Lamrani-Ghaouti, Renaud Sabatier, Joseph Ciccolini, Jean-Marie Boher

    Published 2023-05-01
    Get full text
    Article
  18. 18
    Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression

    Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression by Marjolaine Ngollo, Andre Lebert, Marine Daures, Gaelle Judes, Khaldoun Rifai, Lucas Dubois, Jean-Louis Kemeny, Frederique Penault-Llorca, Yves-Jean Bignon, Laurent Guy, Dominique Bernard-Gallon

    Published 2017-04-01
    Get full text
    Article
  19. 19
    Telomere Status of Advanced Non-Small-Cell Lung Cancer Offers a Novel Promising Prognostic and Predictive Biomarker

    Telomere Status of Advanced Non-Small-Cell Lung Cancer Offers a Novel Promising Prognostic and Predictive Biomarker by Eve Faugeras, Lauren Véronèse, Gaëlle Jeannin, Henri Janicot, Sébastien Bailly, Jacques-Olivier Bay, Bruno Pereira, Anne Cayre, Frédérique Penault-Llorca, Florent Cachin, Patrick Merle, Andrei Tchirkov

    Published 2022-12-01
    Get full text
    Article
  20. 20
    Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis

    Tumour-infiltrating lymphocytes in non-invasive breast cancer: A systematic review and meta-analysis by Rafael Caparica, Marco Bruzzone, Elisa Agostinetto, Maria Alice Franzoi, Marcello Ceppi, Nina Radosevic-Robin, Frédérique Penault-Llorca, Karen Willard-Gallo, Sherene Loi, Roberto Salgado, Evandro de Azambuja

    Published 2021-10-01
    Get full text
    Article

Search Tools: